ZongSheng Pharmaceutical Industry: Obtained the drug registration certificate for cyclosporine eye drops and compound tropicamide eye drops.

Zhongsheng Pharmaceutical announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for cyclosporine eye drops and compound tropicamide eye drops. Cyclosporine eye drops are clinically used to treat severe vernal keratoconjunctivitis in children aged 4 and above, while compound tropicamide eye drops are clinically used for diagnostic and therapeutic purposes of mydriasis and cycloplegia. Obtaining the "Drug Registration Certificate" this time will help enhance the company's market competitiveness and is expected to have a positive impact on the company's future performance.